AcquisitionMethod: LC-MS/MS
Age: 2-3 months old
Age: 4-6 week old
AlkylationReagent: iodoacetamide (IAA)
Bait: protein A/G plus agarose beads
CellLine: P. falciparum D10
CellLine: P. falciparum 3D7
Chromatography: strong cation exchange chromatography (SCX)
Chromatography: reversed-phase liquid chromatography (RP)
Chromatography: Xbridge C18
CleavageAgent: chymotrypsin
CleavageAgent: trypsin
EnrichmentMethod: immobilized metal affinity chromatography (IMAC)
Experiment: phosphoproteomics
Experiment: proteomics
FlowRate: 1 ml flow rate per minute
FractionationMethod: offline fractionation
FragmentationMethod: Higher-energy collisional dissociation
FragmentationMethod: Collision-induced dissociation
GradientTime: 60 min
GradientTime: 120 min
Instrument: Agilent 1100 binary pump
Instrument: Proxeon Easy-nLC 1000 system
Instrument: Agilent Technologies
Instrument: Orbitrap Fusion Tribrid mass spectrometer
Instrument: Waters Corporation,Xbridge C18 5 um 250 x 4.6 mm column
Instrument: Thermo Fisher Scientific
Label: iTRAQ
MS2Analyzer: Orbitrap
MissedCleavages: 1
Modification: carbamidomethylation
Modification: phosphorylation
Modification: oxidation of methionine
NumberOfFractions: 12
NumberOfFractions: 96
NumberOfTechnicalReplicates: technical duplicates
Organism: Homo sapiens
Organism: Mus musculus
Organism: Plasmodium falciparum
Organism: rabbit
QuantificationMethod: iTRAQ
ReductionReagent: DTT
ReductionReagent: Dithiothreitol
SearchEngine: Mascot
SearchEngine: Sequest
Separation: reversed-phase liquid chromatography
Strain: D10
Strain: 3D7
Strain: New Zealand
Strain: Balb/c
TechnologyType: LC-MS/MS
Temperature: 37 degreesC
Temperature: room temperature
Temperature: 4 degreesC
Treatment: WR99210
Treatment: Shld-1
Treatment: PKA Inhibitor PKI
Treatment: 8Br-cAMP
Treatment: BAPTA-AM
Treatment: Neuraminidase
Treatment: trypsin
Treatment: chymotrypsin
Treatment: pharmacological inhibitors
Treatment: cytochalasin D
Treatment: DMSO